ECRAID-PRIME

Belgium France Germany Ireland Poland Spain United Kingdom Georgia
|
2021
  • Adults
  • Primary care
  • Community
  • Influenza A(H5N1) virus
  • SARS-CoV-2
  • Influenza virus
  • Acute SARS-CoV-2
  • Avian Influenza
  • Flu
  • Pharmacological intervention
  • Nitric Oxide Nasal Spray

Zurich Coronavirus Cohort

Switzerland
|
2020
  • Adults
  • General population
  • Non-hospital health centre
  • Community
  • SARS-CoV-2
  • Post-COVID-19
  • Blood sample
  • Saliva sample

ORCHESTRA WP2 prospective cohort

France Italy Spain Congo Argentina The Netherlands
|
2020-2024
  • Adults
  • Hospital wide
  • Outpatient clinic
  • Primary care
  • Community
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Post-COVID-19
  • Blood sample
  • Stool sample
  • Nasopharyngeal swab
  • PBMC
  • Serum
  • Whole blood
  • Plasma

Tibble

United Kingdom
|
2021-2022
  • Adults
  • Paediatric
  • Elderly
  • General population
  • Hospital wide
  • Outpatient clinic
  • Non-hospital health centre
  • Community
  • SARS-CoV-2
  • Acute SARS-CoV-2

TLCĀ 

United Kingdom
|
2021
  • Adults
  • General population
  • Primary care
  • Community
  • SARS-CoV-2
  • Post-COVID-19

Sanz-Munoz

Spain
|
2021-2022
  • Adults
  • Elderly
  • General population
  • Non-hospital health centre
  • Community
  • Long-term care facility
  • Influenza A(H5N1) virus
  • Influenza virus
  • Influenza A(H7N9) virus
  • Avian Influenza
  • Vaccination
  • Pharmacological intervention

Evans

United Kingdom
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Outpatient clinic
  • Non-hospital health centre
  • Community
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Molnupiravir

Drysdale

United Kingdom
|
2021-2022
  • Adults
  • Paediatric
  • Elderly
  • Immunocompromised host
  • Fragile population
  • Outpatient clinic
  • Non-hospital health centre
  • Community
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab